Send mail to Author

A phase I study of a dual PI3-kinase/mTOR inhibitor BEZ235 in adult patients with relapsed or refractory acute leukemia (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _____     ______   _____      _____    __   _     ______  
 /  ___||  /_   _// |  __ \\   |  ___|| | || | ||  /_   _// 
| // __     -| ||-  | |  \ ||  | ||__   | '--' ||   -| ||-  
| \\_\ ||   _| ||_  | |__/ ||  | ||__   | .--. ||   _| ||_  
 \____//   /_____// |_____//   |_____|| |_|| |_||  /_____// 
  `---`    `-----`   -----`    `-----`  `-`  `-`   `-----`
 


Back to frontdoor view

OPUS4 Logo